Rating History for Arena Pharma (ARNA) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/14/2021 | Joshua Schwartz | Downgrade | Market Perform (Outperform) |
100.00 (N/A) |
90.08 (99.98) |
10.99% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/14/2021 | Joshua Schwartz | Downgrade | Market Perform (Outperform) |
100.00 (N/A) |
90.08 (99.98) |
10.99% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||